Therapeutic apheresis in the treatment of hemolytic uremic syndrome in view of pathophysiological aspects.
about
Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study[Treatment of typical hemolytic-uremic syndrome. Knowledge gained from analyses of the 2011 E. coli outbreak].Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab.Case Report: Severe form of hemolytic-uremic syndrome with multiple organ failure in a child: a case report.Therapeutic Apheresis in Immunologic Renal and Neurological Diseases.Double filtration plasmapheresis in different diseases in Thailand.
P2860
Therapeutic apheresis in the treatment of hemolytic uremic syndrome in view of pathophysiological aspects.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Therapeutic apheresis in the t ...... of pathophysiological aspects.
@ast
Therapeutic apheresis in the t ...... of pathophysiological aspects.
@en
type
label
Therapeutic apheresis in the t ...... of pathophysiological aspects.
@ast
Therapeutic apheresis in the t ...... of pathophysiological aspects.
@en
prefLabel
Therapeutic apheresis in the t ...... of pathophysiological aspects.
@ast
Therapeutic apheresis in the t ...... of pathophysiological aspects.
@en
P2093
P2860
P1476
Therapeutic apheresis in the t ...... of pathophysiological aspects.
@en
P2093
Ralf Schiel
Reinhard Latza
Rolf Bambauer
P2860
P356
10.1111/J.1744-9987.2010.00903.X
P577
2011-02-01T00:00:00Z